Zimmer Biomet Holdings (ZBH) Cash from Investing Activities (2009 - 2026)

Zimmer Biomet Holdings has reported Cash from Investing Activities for 18 years, with the latest figure at -$190.8 million in Q2 2026.

• On a quarterly basis, Cash from Investing Activities rose 86.22% year-over-year to -$190.8 million in Q2 2026; TTM through Jun 2026 was -$835.1 million, a 56.88% increase from a year earlier, with the FY2025 full-year figure at -$2.0 billion, down 122.46% from the prior year.
• Cash from Investing Activities was -$190.8 million for Q2 2026 at Zimmer Biomet Holdings, down from -$159.0 million in the prior quarter.
• The five-year high for Cash from Investing Activities was -$81.1 million in Q1 2022, with the low at -$1.4 billion in Q2 2025.
• Average Cash from Investing Activities over 5 years is -$250.8 million, with a median of -$178.2 million recorded in 2023.
• The sharpest annual moves came in 2025 and 2026: Cash from Investing Activities plunged 460.49% in 2025, then jumped 86.22% in 2026.
• Over 5 years, Cash from Investing Activities stood at -$112.5 million in 2022, then tumbled by 96.27% to -$220.8 million in 2023, then tumbled by 31.88% to -$291.2 million in 2024, then decreased by 10.58% to -$322.0 million in 2025, then soared by 40.75% to -$190.8 million in 2026.
• The last three Cash from Investing Activities figures came in at -$190.8 million (Q2 2026), -$159.0 million (Q1 2026), and -$322.0 million (Q4 2025), per Business Quant data.